Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004352 (
autism
)
32,579
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Genetic and environmental factors are both likely to contribute to neurodevelopmental disorders, including ASDs (
autism
spectrum disorders). In this study, we examined the combinatorial effect of two factors thought to be involved in
autism
--reduction in the expression of the extracellular matrix protein reelin and prenatal exposure to an organophosphate pesticide,
CPO
(chlorpyrifos oxon). Mice with reduced reelin expression or prenatal exposure to
CPO
exhibited subtle changes in ultrasound vocalization, open field behaviour, social interaction and repetitive behaviour. Paradoxically, mice exposed to both variables often exhibited a mitigation of abnormal behaviours, rather than increased behavioural abnormalities as expected. We identified specific differences in males and females in response to both of these variables. In addition to behavioural abnormalities, we identified anatomical alterations in the olfactory bulb, piriform cortex, hippocampus and cerebellum. As with our behavioural studies, anatomical alterations appeared to be ameliorated in the presence of both variables. While these observations support an interaction between loss of reelin expression and
CPO
exposure, our results suggest a complexity to this interaction beyond an additive effect of individual phenotypes.
...
PMID:Decreased reelin expression and organophosphate pesticide exposure alters mouse behaviour and brain morphology. 2329 82
Although animal models cannot exactly replicate human psychiatric disorders, they may be useful to investigate whether the behaviors associated with certain exposures in animals parallel those observed in people. According to the most current version of the Diagnostic and Statistical Manual of Mental Disorders,
autism
is diagnosed based on (1) persistent deficits in social communication and social interaction; and (2) the presence of restricted, repetitive patterns of behavior, interests and activities. To address whether developmental chlorpyrifos (CPF) exposure was associated with the development of autistic behaviors, a literature search was conducted to identify studies in rats and mice involving gestational or early postnatal exposure to CPF or CPF oxon (
CPO
, the active metabolite of CPF) and subsequent behavioral testing to assess behaviors related to
autism
. A total of 13 studies conducted in six different laboratories were identified. Analysis of these studies found that perinatal CPF exposure was generally associated with (1) no effect or increased social communications; (2) no effect or increased social encounters; (3) no effect, reduced stereotypies, or conflicting findings on stereotypic behaviors; and (4) no effect or increased preference for novelty and reduced anxiety in novel environments. These behavioral findings are generally inconsistent with the types of behaviors that would be expected in children with clinical
autism
. Based on the results of this analysis of rodent model studies involving CPF/
CPO
exposure, it cannot be concluded that gestational and/or perinatal CPF exposure is likely to be associated with the development of
autism
-like behaviors in humans.
...
PMID:Gestational/perinatal chlorpyrifos exposure is not associated with autistic-like behaviors in rodents. 2486 50